Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 444

1.

Neural Mechanisms of Self-Affirmation's Stress Buffering Effects.

Dutcher JM, Eisenberger NI, Woo H, Klein WMP, Harris PR, Levine JM, Creswell JD.

Soc Cogn Affect Neurosci. 2020 Apr 4. pii: nsaa042. doi: 10.1093/scan/nsaa042. [Epub ahead of print]

2.

On the Shoulders of Giants: The Evolution of Renal Cell Carcinoma Treatment-Cytokines, Targeted Therapy, and Immunotherapy.

Dutcher JP, Flippot R, Fallah J, Escudier B.

Am Soc Clin Oncol Educ Book. 2020 Mar;40:1-18. doi: 10.1200/EDBK_280817.

3.

Management of hepatitis B in the era of checkpoint inhibition.

Dutcher J.

J Immunother Cancer. 2020 Feb;8(1). pii: e000276. doi: 10.1136/jitc-2019-000276.

4.

Associations between amygdala reactivity to social threat, perceived stress, and C-reactive protein in breast cancer survivors.

Leschak CJ, Dutcher JM, Byrne Haltom KE, Breen EC, Bower JE, Eisenberger NI.

Soc Cogn Affect Neurosci. 2020 Feb 10. pii: nsz103. doi: 10.1093/scan/nsz103. [Epub ahead of print]

5.

Commentary: One nano-step for murinekind, one giant leap for mesothelioma.

Dutcher JS, D'Cunha J.

J Thorac Cardiovasc Surg. 2020 Jan 11. pii: S0022-5223(20)30085-4. doi: 10.1016/j.jtcvs.2019.12.092. [Epub ahead of print] No abstract available.

PMID:
32033819
6.

Review of Published Curriculum on Sex Trafficking for Undergraduate Medical Trainees.

Talbott JMV, Dutcher JS, Pougnier CA, Calvin SL, Roe-Sepowitz D, Kling JM.

Am J Prev Med. 2020 Apr;58(4):604-611. doi: 10.1016/j.amepre.2019.11.013. Epub 2020 Jan 28.

PMID:
32005592
7.

NCI 6896: a phase I trial of vorinostat (SAHA) and isotretinoin (13-cis retinoic acid) in the treatment of patients with advanced renal cell carcinoma.

Molina AM, van der Mijn JC, Christos P, Wright J, Thomas C, Dutcher JP, Nanus DM, Tagawa ST, Gudas LJ.

Invest New Drugs. 2020 Jan 3. doi: 10.1007/s10637-019-00880-7. [Epub ahead of print]

PMID:
31898184
8.

Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial.

Lee Z, Jegede OA, Haas NB, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Flaherty KT, Dutcher JP, DiPaola RS, Uzzo RG.

J Urol. 2020 Apr;203(4):684-689. doi: 10.1097/JU.0000000000000588. Epub 2019 Oct 9.

PMID:
31596672
9.

Angiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell Carcinoma.

Xu W, Puligandla M, Manola J, Bullock AJ, Tamasauskas D, McDermott DF, Atkins MB, Haas NB, Flaherty K, Uzzo RG, Dutcher JP, DiPaola RS, Bhatt RS.

Clin Cancer Res. 2019 Oct 15;25(20):6098-6106. doi: 10.1158/1078-0432.CCR-19-0818. Epub 2019 Aug 30.

PMID:
31471309
10.

Identifying Behavioral Phenotypes of Loneliness and Social Isolation with Passive Sensing: Statistical Analysis, Data Mining and Machine Learning of Smartphone and Fitbit Data.

Doryab A, Villalba DK, Chikersal P, Dutcher JM, Tumminia M, Liu X, Cohen S, Creswell K, Mankoff J, Creswell JD, Dey AK.

JMIR Mhealth Uhealth. 2019 Jul 24;7(7):e13209. doi: 10.2196/13209.

11.

Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation.

Correa AF, Jegede O, Haas NB, Flaherty KT, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Dutcher JP, DiPaola RS, Carducci MA, Uzzo RG.

J Clin Oncol. 2019 Aug 10;37(23):2062-2071. doi: 10.1200/JCO.19.00107. Epub 2019 Jun 19.

12.

Null results of oxytocin and vasopressin administration across a range of social cognitive and behavioral paradigms: Evidence from a randomized controlled trial.

Tabak BA, Teed AR, Castle E, Dutcher JM, Meyer ML, Bryan R, Irwin MR, Lieberman MD, Eisenberger NI.

Psychoneuroendocrinology. 2019 Sep;107:124-132. doi: 10.1016/j.psyneuen.2019.04.019. Epub 2019 Apr 29.

PMID:
31128568
13.

Sex Differences in the Relationship Between Inflammation and Reward Sensitivity: A Randomized Controlled Trial of Endotoxin.

Moieni M, Tan KM, Inagaki TK, Muscatell KA, Dutcher JM, Jevtic I, Breen EC, Irwin MR, Eisenberger NI.

Biol Psychiatry Cogn Neurosci Neuroimaging. 2019 Jul;4(7):619-626. doi: 10.1016/j.bpsc.2019.03.010. Epub 2019 Apr 3.

PMID:
31103547
14.

Overall survival by clinical risk category for high dose interleukin-2 (HD IL-2) treated patients with metastatic renal cell cancer (mRCC): data from the PROCLAIMSM registry.

Fishman M, Dutcher JP, Clark JI, Alva A, Miletello GP, Curti B, Agarwal N, Hauke R, Mahoney KM, Moon H, Treisman J, Tykodi SS, Daniels G, Morse MA, Wong MKK, Kaufman H, Gregory N, McDermott DF.

J Immunother Cancer. 2019 Mar 27;7(1):84. doi: 10.1186/s40425-019-0567-3.

15.

Therapy with high-dose Interleukin-2 (HD IL-2) in metastatic melanoma and renal cell carcinoma following PD1 or PDL1 inhibition.

Buchbinder EI, Dutcher JP, Daniels GA, Curti BD, Patel SP, Holtan SG, Miletello GP, Fishman MN, Gonzalez R, Clark JI, Richart JM, Lao CD, Tykodi SS, Silk AW, McDermott DF.

J Immunother Cancer. 2019 Feb 18;7(1):49. doi: 10.1186/s40425-019-0522-3.

16.

Changes in eudaimonic well-being and the conserved transcriptional response to adversity in younger breast cancer survivors.

Boyle CC, Cole SW, Dutcher JM, Eisenberger NI, Bower JE.

Psychoneuroendocrinology. 2019 May;103:173-179. doi: 10.1016/j.psyneuen.2019.01.024. Epub 2019 Jan 23.

PMID:
30703712
17.

Association between age and sex and mortality after adjuvant therapy for renal cancer.

Mamtani R, Wang XV, Gyawali B, DiPaola RS, Epperson CN, Haas NB, Dutcher JP.

Cancer. 2019 May 15;125(10):1637-1644. doi: 10.1002/cncr.31955. Epub 2019 Jan 8.

PMID:
30620389
18.

The role of brain reward pathways in stress resilience and health.

Dutcher JM, Creswell JD.

Neurosci Biobehav Rev. 2018 Dec;95:559-567. doi: 10.1016/j.neubiorev.2018.10.014. Review.

PMID:
30477985
19.

Nanofibres induce remodelling of cell membranes.

Dutcher JR.

Nature. 2018 Nov;563(7732):481-482. doi: 10.1038/d41586-018-07261-9. No abstract available.

PMID:
30459369
20.

Update on the biology and management of renal cell carcinoma.

Dutcher JP.

J Investig Med. 2019 Jan;67(1):1-10. doi: 10.1136/jim-2018-000918. Epub 2018 Nov 18. Review.

PMID:
30455223
21.

Fundamental science and discoveries at the interface of microbiology and physics.

Dutcher JR.

Can J Microbiol. 2018 Sep;64(9):639-641. doi: 10.1139/cjm-2018-0176. No abstract available.

22.

Interleukin-2 Can Cure Kidney Cancer.

Dutcher JP, Wiernik PH.

Oncologist. 2018 Sep;23(9):e107. doi: 10.1634/theoncologist.2018-0038. Epub 2018 Aug 13. No abstract available.

23.

Unusual polysaccharide rheology of aqueous dispersions of soft phytoglycogen nanoparticles.

Shamana H, Grossutti M, Papp-Szabo E, Miki C, Dutcher JR.

Soft Matter. 2018 Aug 8;14(31):6496-6505. doi: 10.1039/c8sm00815a.

PMID:
30043804
24.

"Pseudoprogression": more than semantics.

Dutcher JP.

Cancer Immunol Immunother. 2018 Sep;67(9):1473-1474. doi: 10.1007/s00262-018-2208-y. Epub 2018 Jul 18. No abstract available.

PMID:
30022219
25.

Behavioral interventions in health neuroscience.

Dutcher JM, Creswell JD.

Ann N Y Acad Sci. 2018 Sep;1428(1):51-70. doi: 10.1111/nyas.13913. Epub 2018 Jun 26. Review.

26.

Pulmonary Langerhans cell histiocytosis, acute myeloid leukemia, and myelofibrosis in a large family and review of the literature.

Blakley MP, Dutcher JP, Wiernik PH.

Leuk Res. 2018 Apr;67:39-44. doi: 10.1016/j.leukres.2018.01.011. Epub 2018 Feb 2. Review.

PMID:
29428448
27.

Supraclavicular Subclavian access for Sapien Transcatheter aortic valve replacement- a novel approach.

Dahle TG, Castro NJ, Stegman BM, Dutcher JR, Teskey JM, Schmidt WT, Danielson DS, Dezell SJ, Daniels VB, Tiede DJ.

J Cardiothorac Surg. 2018 Jan 30;13(1):16. doi: 10.1186/s13019-018-0706-9.

28.

Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry.

Curti B, Daniels GA, McDermott DF, Clark JI, Kaufman HL, Logan TF, Singh J, Kaur M, Luna TL, Gregory N, Morse MA, Wong MKK, Dutcher JP.

J Immunother Cancer. 2017 Dec 19;5(1):102. doi: 10.1186/s40425-017-0307-5.

29.

A Randomized Phase II Study to Determine the Effect of 2 Different Doses of Aflibercept in Patients With Metastatic Renal Cell Carcinoma (ECOG-ACRIN [E4805]).

Pili R, Jegede O, Carducci MA, Manola J, Groteluschen DL, Appleman LL, Liu G, Shanks JC, Dakhil SR, Dutcher J, DiPaola RS.

Clin Genitourin Cancer. 2017 Dec;15(6):642-651.e1. doi: 10.1016/j.clgc.2017.04.023. Epub 2017 Apr 26.

30.

Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial.

Haas NB, Manola J, Dutcher JP, Flaherty KT, Uzzo RG, Atkins MB, DiPaola RS, Choueiri TK.

JAMA Oncol. 2017 Sep 1;3(9):1249-1252. doi: 10.1001/jamaoncol.2017.0076.

31.

Equilibrium Swelling, Interstitial Forces, and Water Structuring in Phytoglycogen Nanoparticle Films.

Grossutti M, Bergmann E, Baylis B, Dutcher JR.

Langmuir. 2017 Mar 21;33(11):2810-2816. doi: 10.1021/acs.langmuir.7b00025. Epub 2017 Mar 10.

PMID:
28244760
32.

Long-Term Response and Possible Cure of Patients With B-Cell Malignancies With Dose-Escalated Rituximab.

Jacobs LM, Wiernik PH, Dutcher JP, Muxi P.

J Investig Med High Impact Case Rep. 2017 Feb 1;5(1):2324709617691307. doi: 10.1177/2324709617691307. eCollection 2017 Jan-Mar.

33.

Impact of Sequencing Targeted Therapies With High-dose Interleukin-2 Immunotherapy: An Analysis of Outcome and Survival of Patients With Metastatic Renal Cell Carcinoma From an On-going Observational IL-2 Clinical Trial: PROCLAIMSM.

Clark JI, Wong MKK, Kaufman HL, Daniels GA, Morse MA, McDermott DF, Agarwala SS, Lewis LD, Stewart JH, Vaishampayan U, Curti B, Gonzalez R, Lutzky J, Rudraptna V, Cranmer LD, Jeter JM, Hauke RJ, Miletello G, Milhem MM, Amin A, Richart JM, Fishman M, Hallmeyer S, Patel SP, Van Veldhuizen P, Agarwal N, Taback B, Treisman JS, Ernstoff MS, Perritt JC, Hua H, Rao TB, Dutcher JP, Aung S.

Clin Genitourin Cancer. 2017 Feb;15(1):31-41.e4. doi: 10.1016/j.clgc.2016.10.008. Epub 2016 Oct 29.

34.

Contemporary experience with high-dose interleukin-2 therapy and impact on survival in patients with metastatic melanoma and metastatic renal cell carcinoma.

Alva A, Daniels GA, Wong MK, Kaufman HL, Morse MA, McDermott DF, Clark JI, Agarwala SS, Miletello G, Logan TF, Hauke RJ, Curti B, Kirkwood JM, Gonzalez R, Amin A, Fishman M, Agarwal N, Lowder JN, Hua H, Aung S, Dutcher JP.

Cancer Immunol Immunother. 2016 Dec;65(12):1533-1544. Epub 2016 Oct 6.

35.

A retrospective analysis of High-Dose Interleukin-2 (HD IL-2) following Ipilimumab in metastatic melanoma.

Buchbinder EI, Gunturi A, Perritt J, Dutcher J, Aung S, Kaufman HL, Ernstoff MS, Miletello GP, Curti BD, Daniels GA, Patel SP, Kirkwood JM, Hallmeyer S, Clark JI, Gonzalez R, Richart JM, Lutzky J, Morse MA, Sullivan RJ, McDermott DF.

J Immunother Cancer. 2016 Sep 20;4:52. doi: 10.1186/s40425-016-0155-8. eCollection 2016.

36.

Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families.

Dutcher JP, Wiernik PH, Varella L, Chintapatla R.

Fam Cancer. 2016 Oct;15(4):677-87. doi: 10.1007/s10689-016-9911-7.

PMID:
27334456
37.

Pure Red Cell Aplasia Following Interleukin-2 Therapy.

Dutcher JP, Fan W, Wiernik PH.

J Investig Med High Impact Case Rep. 2016 Apr 11;4(2):2324709616643991. doi: 10.1177/2324709616643991. eCollection 2016 Apr-Jun.

38.

Oxytocin, but not vasopressin, impairs social cognitive ability among individuals with higher levels of social anxiety: a randomized controlled trial.

Tabak BA, Meyer ML, Dutcher JM, Castle E, Irwin MR, Lieberman MD, Eisenberger NI.

Soc Cogn Affect Neurosci. 2016 Aug;11(8):1272-9. doi: 10.1093/scan/nsw041. Epub 2016 Apr 6.

39.

Exposure to an inflammatory challenge enhances neural sensitivity to negative and positive social feedback.

Muscatell KA, Moieni M, Inagaki TK, Dutcher JM, Jevtic I, Breen EC, Irwin MR, Eisenberger NI.

Brain Behav Immun. 2016 Oct;57:21-29. doi: 10.1016/j.bbi.2016.03.022. Epub 2016 Mar 28.

40.

Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial.

Haas NB, Manola J, Uzzo RG, Flaherty KT, Wood CG, Kane C, Jewett M, Dutcher JP, Atkins MB, Pins M, Wilding G, Cella D, Wagner L, Matin S, Kuzel TM, Sexton WJ, Wong YN, Choueiri TK, Pili R, Puzanov I, Kohli M, Stadler W, Carducci M, Coomes R, DiPaola RS.

Lancet. 2016 May 14;387(10032):2008-16. doi: 10.1016/S0140-6736(16)00559-6. Epub 2016 Mar 9. Erratum in: Lancet. 2016 May 14;387(10032):1998.

41.

Self-Affirmation Activates the Ventral Striatum: A Possible Reward-Related Mechanism for Self-Affirmation.

Dutcher JM, Creswell JD, Pacilio LE, Harris PR, Klein WM, Levine JM, Bower JE, Muscatell KA, Eisenberger NI.

Psychol Sci. 2016 Apr;27(4):455-66. doi: 10.1177/0956797615625989. Epub 2016 Feb 25.

PMID:
26917214
42.

Structure and Hydration of Highly-Branched, Monodisperse Phytoglycogen Nanoparticles.

Nickels JD, Atkinson J, Papp-Szabo E, Stanley C, Diallo SO, Perticaroli S, Baylis B, Mahon P, Ehlers G, Katsaras J, Dutcher JR.

Biomacromolecules. 2016 Mar 14;17(3):735-43. doi: 10.1021/acs.biomac.5b01393. Epub 2016 Feb 11.

PMID:
26866896
43.

Correlation Between Chain Architecture and Hydration Water Structure in Polysaccharides.

Grossutti M, Dutcher JR.

Biomacromolecules. 2016 Mar 14;17(3):1198-204. doi: 10.1021/acs.biomac.6b00026. Epub 2016 Feb 19.

PMID:
26859153
44.

Effect of Renal Impairment on the Pharmacokinetics and Safety of Axitinib.

Chen Y, Rini BI, Motzer RJ, Dutcher JP, Rixe O, Wilding G, Stadler WM, Tarazi J, Garrett M, Pithavala YK.

Target Oncol. 2016 Apr;11(2):229-34. doi: 10.1007/s11523-015-0389-2.

45.

Links between inflammation, amygdala reactivity, and social support in breast cancer survivors.

Muscatell KA, Eisenberger NI, Dutcher JM, Cole SW, Bower JE.

Brain Behav Immun. 2016 Mar;53:34-38. doi: 10.1016/j.bbi.2015.09.008. Epub 2015 Sep 15.

46.

Effect of Skin-to-Skin Holding on Stress in Mothers of Late-Preterm Infants: A Randomized Controlled Trial.

Samra HA, Dutcher J, McGrath JM, Foster M, Klein L, Djira G, Hansen J, Wallenburg D.

Adv Neonatal Care. 2015 Oct;15(5):354-64. doi: 10.1097/ANC.0000000000000223.

PMID:
26356086
47.

Renal cell carcinoma in patients with a personal or family history of hematologic malignancies.

Dutcher JP, Wiernik PH.

Clin Adv Hematol Oncol. 2015 Jun;13(6):392-7.

PMID:
26352895
48.

Families with both Hodgkin lymphoma and multiple myeloma in their pedigrees.

Wiernik PH, Wickramasinghe D, Dutcher JP.

Clin Adv Hematol Oncol. 2015 Apr;13(4):257-60.

PMID:
26352584
49.

Proteome Profiles of Outer Membrane Vesicles and Extracellular Matrix of Pseudomonas aeruginosa Biofilms.

Couto N, Schooling SR, Dutcher JR, Barber J.

J Proteome Res. 2015 Oct 2;14(10):4207-22. doi: 10.1021/acs.jproteome.5b00312. Epub 2015 Sep 15.

PMID:
26303878
50.

Atrasentan in Patients With Advanced Renal Cell Carcinoma: A Phase 2 Trial of the ECOG-ACRIN Cancer Research Group (E6800).

Carducci MA, Manola J, Nair SG, Liu G, Rousey S, Dutcher JP, Wilding G.

Clin Genitourin Cancer. 2015 Dec;13(6):531-539.e1. doi: 10.1016/j.clgc.2015.07.002. Epub 2015 Jul 17.

Supplemental Content

Loading ...
Support Center